
|
Forward
Looking Statements: This news release includes certain
forward-looking statements, which are subject to various risks and
uncertainties. Actual results could differ materially from those currently
anticipated due to a number of factors, including but not limited to the
integration of CJ into our existing operations, the size, structure and
growth of the Company's air medical services and products markets; the
collection rates for patient transports; the continuation and/or renewal
of air medical service contracts; the acquisition of profitable Products
Division contracts and other flight service operations; the successful
expansion of the community-based operations; and other matters set forth
in the Company's public filings.
|
|
March 31, 2008
|
December 31, 2007
|
|||||||
|
ASSETS
|
||||||||
|
Current
assets:
|
||||||||
|
Cash
and cash equivalents
|
$ | 12,510 | 5,134 | |||||
|
Trade
receivables, net
|
127,530 | 135,633 | ||||||
|
Other
current assets
|
63,392 | 74,090 | ||||||
|
Total
current assets
|
203,432 | 214,857 | ||||||
|
Net
property and equipment
|
110,473 | 114,746 | ||||||
|
Other
assets, net
|
42,704 | 39,949 | ||||||
|
Total
assets
|
$ | 356,609 | 369,552 | |||||
|
LIABILITIES AND
STOCKHOLDERS' EQUITY
|
||||||||
|
Current
liabilities:
|
||||||||
|
Notes
payable related to assets held for sale
|
$ | 12,549 | 24,203 | |||||
|
Current
portion of indebtedness
|
18,612 | 18,350 | ||||||
|
Accounts
payable, accrued expenses and other
|
57,104 | 59,546 | ||||||
|
Total
current liabilities
|
88,265 | 102,099 | ||||||
|
Long-term
indebtedness
|
74,829 | 76,751 | ||||||
|
Other
non-current liabilities
|
48,108 | 48,682 | ||||||
|
Total
liabilities
|
211,202 | 227,532 | ||||||
|
Total
stockholders' equity
|
145,407 | 142,020 | ||||||
|
Total
liabilities and stockholders' equity
|
$ | 356,609 | 369,552 | |||||
|
Quarter
Ended
|
||||||||
|
March
31,
|
||||||||
|
2008
|
2007
|
|||||||
|
Revenue:
|
||||||||
|
Flight
operations
|
$ | 114,473 | 79,161 | |||||
|
Product
operations
|
3,626 | 2,297 | ||||||
|
Total
revenue
|
118,099 | 81,458 | ||||||
|
Expenses:
|
||||||||
|
Operating
expenses
|
91,979 | 58,493 | ||||||
|
General
and administrative
|
17,146 | 12,151 | ||||||
|
Depreciation
and amortization
|
4,098 | 3,411 | ||||||
| 113,223 | 74,055 | |||||||
|
Operating
income
|
4,876 | 7,403 | ||||||
|
Interest
expense
|
(1,567 | ) | (1,422 | ) | ||||
|
Other,
net
|
643 | 455 | ||||||
|
Income
before income taxes
|
3,952 | 6,436 | ||||||
|
Income
tax expense
|
(1,622 | ) | (2,738 | ) | ||||
|
Net
income
|
$ | 2,330 | 3,698 | |||||
|
Income
per common share:
|
||||||||
|
Basic
|
$ | 0.19 | 0.31 | |||||
|
Diluted
|
$ | 0.18 | 0.30 | |||||
|
Weighted
average common shares outstanding - basic
|
12,151,342 | 11,876,835 | ||||||
|
Weighted
average common shares outstanding - diluted
|
12,623,358 | 12,362,198 | ||||||